Russell Frank Company’s Jazz Pharmaceuticals JAZZ Stock Holding History

Russell Frank Company’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$7.71M	Sell	59,024 -5,692	-9%	-$709K	0.01%	1095
2015 Q4	$9.25M	Buy	64,716 +19,112	+42%	+$2.65M	0.02%	929
2015 Q3	$6.06M	Sell	45,604 -4,423	-9%	-$762K	0.01%	1162
2015 Q2	$8.81M	Buy	50,027 +7,333	+17%	+$1.32M	0.01%	1078
2015 Q1	$7.38M	Sell	42,694 -1,548	-3%	-$266K	0.01%	1025
2014 Q4	$7.22M	Sell	44,242 -8,298	-16%	-$1.38M	0.01%	1063
2014 Q3	$8.44M	Sell	52,540 -19,681	-27%	-$3.03M	0.02%	980
2014 Q2	$10.6M	Sell	72,221 -16,839	-19%	-$2.34M	0.02%	886
2014 Q1	$12.4M	Buy	89,060 +12,233	+16%	+$1.84M	0.02%	768
2013 Q4	$9.74M	Sell	76,827 -21,802	-22%	-$2.26M	0.02%	872
2013 Q3	$9.07M	Sell	98,629 -36,612	-27%	-$2.95M	0.02%	952
2013 Q2	$9.29M	Buy	+135,241	New	+$8.27M	0.02%	892

Other funds holding JAZZ

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Russell Frank Company's JAZZ Position: Q1 2016 in Review

Russell Frank Company reduced its Jazz Pharmaceuticals (JAZZ) stake by 8.8% in Q1 2016, selling an estimated $709K and leaving 59,024 shares worth $7.71M. The position accounts for 0.01% of the portfolio, ranked #1095.

Russell Frank Company first reported a position in JAZZ in Q2 2013 and has held it in 12 quarters since. The position peaked at $12.4M in Q1 2014. 339 funds tracked by Wall St. Rank hold JAZZ as of Q1 2016.

Russell Frank Company held 59,024 shares of Jazz Pharmaceuticals worth $7.71M as of Q1 2016.
Russell Frank Company sold 5,692 Jazz Pharmaceuticals shares in Q1 2016, an estimated $709K.
Jazz Pharmaceuticals made up 0.01% of Russell Frank Company's portfolio in Q1 2016, its #1095 holding.
Russell Frank Company first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 12 quarters since.
Russell Frank Company's Jazz Pharmaceuticals position peaked at $12.4M in Q1 2014.
339 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.